Skip to main content
SpringerLink
Log in

Is BRCA1/2 testing for women at high cancer risk cost effective in Brazil?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Correa-Galendi JS, et al. Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer. Applied Health Economics and Health Policy : 15 Jun 2020. Available from: URL: https://doi.org/10.1007/s40258-020-00599-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Is BRCA1/2 testing for women at high cancer risk cost effective in Brazil?. PharmacoEcon Outcomes News 856, 18 (2020). https://doi.org/10.1007/s40274-020-6918-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6918-y

Search

Navigation